BioArctic revenue and financials
kr 303.80Change from previous close: +0.86%Absolute change: +kr 2.60
In the fiscal year ended December 2025, BioArctic reported revenue of kr 2B (+676.80% year over year). Net income was kr 1.02B, a net margin of 51.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +676.80%
- 2025 vs 2024
- Net margin
- 51.1%
- 2024: -68.8%
Financial data
Amounts in millions of SEK; per-share values in SEK; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 2,575 | 1,112 | 1,186 | 858 | — |
| Current assets | 2,487 | 1,011 | 1,153 | 821 | — |
| Cash and equivalents | 1,040 | 513 | 612 | 805 | — |
| Short-term investments | 1,150 | 266 | 500 | — | — |
| Net property, plant and equipment | 83.0 | 96.6 | 31.1 | 35.3 | — |
| Current liabilities | 521 | 176 | 125 | 70.9 | — |
| Accounts payable | 23.9 | 50.5 | 29.9 | 21.5 | — |
| Total debt | 44.1 | 54.2 | 5.0 | 10.0 | — |
| Total liabilities | 608 | 217 | 140 | 72.1 | — |
| Total equity (incl. minority) | 1,967 | 895 | 1,047 | 786 | — |
| Retained earnings | 1,351 | 305 | 463 | 218 | — |